Back
Protagonist Therapeutics Vs. John Wiley & Sons Industry Stock Comparison
Sell
47
PTGX
Protagonist Therapeutics
Last Price:
44.54
Seasonality Move:
15.58%
Sell
43
WLY
John Wiley & Sons
Last Price:
48.06
Seasonality Move:
2.42%
Sell
47
Protagonist Therapeutics (PTGX)
is a Sell
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $44.93. The Score for PTGX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- PTGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
John Wiley & Sons (WLY)
is a Sell
Is John Wiley & Sons a Buy, Sell or Hold?
- The current John Wiley & Sons [WLY] share price is $47.13. The Score for WLY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- WLY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $44.93
The current trend is moderately bearish and PTGX is experiencing selling pressure, which indicates risk of future bearish movement.
WLY Stock Price Chart
What is John Wiley & Sons's stock price today?
-
The John Wiley & Sons share price today is $47.13
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and WLY is experiencing buying pressure, which is a positive indicator for future bullish movement.
PTGX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.43 | Buy |
Relative Strength Index (14 RSI): | 54.71 | Buy |
Chaikin Money Flow: | -385158 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (42.06 - 46.06) | Buy |
Bollinger Bands (100): | (31.14 - 42.38) | Buy |
WLY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.28 | Buy |
Relative Strength Index (14 RSI): | 56.66 | Buy |
Chaikin Money Flow: | 223333 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44.61 - 47.69) | Buy |
Bollinger Bands (100): | (38.86 - 47) | Buy |
PTGX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 45.84 | Sell |
20-day SMA: | 44.59 | Buy |
50-day SMA: | 41.44 | Buy |
200-day SMA: | 31.51 | Buy |
8-day EMA: | 45.74 | Sell |
20-day EMA: | 44.65 | Buy |
50-day EMA: | 41.66 | Buy |
200-day EMA: | 32.9 | Buy |
WLY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 46.61 | Buy |
20-day SMA: | 45.98 | Buy |
50-day SMA: | 46.08 | Buy |
200-day SMA: | 38.92 | Buy |
8-day EMA: | 46.47 | Buy |
20-day EMA: | 46.14 | Buy |
50-day EMA: | 45.34 | Buy |
200-day EMA: | 40.76 | Buy |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.26 per share, an increase this year of $4.50 per share, and a decrease next year of $2.97 per share.
John Wiley & Sons Earnings Growth & WLY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.00 per share, and an increase next year of $0.26 per share.
Protagonist Therapeutics Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
John Wiley & Sons Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |